Generic placeholder image

Current Psychopharmacology

Author(s): Jyoti Alambayan and Vandana Garg*

DOI: 10.2174/2211556009999200723122833

DownloadDownload PDF Flyer Cite As
Overview on Phyto-based Treatment for Anxiety

Page: [185 - 210] Pages: 26

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Background: The prevalence of psychiatric disorders, such as anxiety, is very common and affects many people all around the world. Currently, many synthetic pharmacological products/ drugs are available in the market to cure the disorder but associated with various adverse reactions or side effects, which may cause discomfort and sometimes other disorders to the patients. In the past years, the use of complementary and alternative medicine has increased. The exploration in the area of herbal psychopharmacology has received much attention as people are using more herbal treatment to benefit their health.

Objective: To provide comprehensive information on anxiety disorder and its herbal treatment.

Methods: In this review, we enlisted the plants, plant extracts and isolated components (if any) along with models used to explore anxiolytic property; in retrospect, still a lot of research required to establish them clinically.

Result: Literature revealed that a variety of medicinal plants are effective for the treatment of anxiety like Ginkgo biloba, Passiflora incarnata, Gelsemium sempervirens, Piper methysticum, Bauhinia variegate, Matricaria recutita, Brassica oleracea, Hypericum perforatum, Echium amoenum, and Scutellaria lateriflora.

Conclusion: Exploration of herbal plants may be beneficial to establish more potential compounds for the treatment of anxiety disorders.

Keywords: Antianxiety models, anxiety, herbs, kava, mechanism, Passiflora, review.

Graphical Abstract

[1]
Edwards J, Goldie I, Elliott I, Breedvelt J, Chakkalackal L, Foye U. Fundamental facts about mental health 2016. London: Mental health foundation 2016.
[2]
World Health Organization. Depression and other common mental disorders: global health estimates. Geneva World Heal Organ 2017; pp. 1-24.
[3]
Brunton LL, Chabner BA, Knollmann BC. Goodman and Gilman’s the pharmacological basis of therapeutics. 12th ed. New Delhi: Mc-graw hill In: 2011.
[4]
Sharma HL, Sharma KK. Principles of Pharmacology. 3rd ed. India: Paras Medical Publishers 2017.
[5]
Rang H, Dale M, Ritter J, Flower R, Henderson G. Rang and Dale’s Pharmacology. 7th ed. London: Churchill Livingstone Elsevier 2011.
[6]
Tripathi KD. Essentials of medical pharmacology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd: 2008.
[7]
Shri R. Anxiety : causes and management. J Behav Sci 2010; 5(1): 100-18.
[8]
Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol 2011; 21(12): 841-60.
[http://dx.doi.org/10.1016/j.euroneuro.2011.04.002 ] [PMID: 21601431]
[9]
Lakhan SE, Vieira KF. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutr J 2010; 9(1): 42.
[http://dx.doi.org/10.1186/1475-2891-9-42 PMID: 20929532]
[10]
Khanum F, Organisation D, Khanum F. Anxiety-herbal treatment : a review. Res Rev Biomed Biotech 2010; 1(2): 71-89.
[11]
Trial P. Herbal and dietary supplements for depression. Harv Ment Health Lett 2008; 25(4): 4-5.
[PMID: 19024764]
[12]
Ernst E. Herbal remedies for depression and anxiety. Adv Psychiatr Treat 2007; 13(4): 312-6.
[http://dx.doi.org/10.1192/apt.bp.105.001735]
[13]
Bhatt A, Sagar M, Chopra H, Ghildiyal P. Herbal remedies to treat anxiety disorders. World J Pharm Pharm Sci 2018; 7(6): 177-89.
[14]
Ernst E. Herbal remedies for anxiety - a systematic review of controlled clinical trials. Phytomedicine 2006; 13(3): 205-8.
[http://dx.doi.org/10.1016/j.phymed.2004.11.006 ] [PMID: 16428031]
[15]
DeSousa A. Herbal medicines and anxiety disorders : an overview. J Med Plants Stud 2013; 1(6): 18-23.
[PMID: 26412068]
[16]
Liu C, Li B, Wang P, Liu L, Wang Y, Li Y. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol 2015; 13(4): 481-93.
[17]
Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci 2015; 17(3): 327-35.
[PMID: 26487813]
[18]
Inoue T, Koyama T. [Anxiety disorder] Brain Nerve 2012; 64(2): 131-8.
[PMID: 22308258]
[19]
Miller JJ, Fletcher K, Kabat-Zinn J. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry 1995; 17(3): 192-200.
[http://dx.doi.org/10.1016/0163-8343(95)00025-M ] [PMID: 7649463]
[20]
Gupta V, Bansal P, Kumar S, Sannd R, Rao M. Therapeutic efficacy of phytochemicals as anti-anxiety-a review. J Pharm Res 2010; 3(1): 174-9.
[21]
Clark DM. Anxiety disorders: why they persist and how to treat them. Behav Res Ther 1999; 37(Suppl. 1): S5-S27.
[http://dx.doi.org/10.1016/S0005-7967(99)00048-0 ] [PMID: 10402694]
[22]
Edge J. A pilot study addressing the effect of aromatherapy massage on mood, anxiety and relaxation in adult mental health. Complement Ther Nurs Midwifery 2003; 9(2): 90-7.
[http://dx.doi.org/10.1016/S1353-6117(02)00104-X ] [PMID: 12697161]
[23]
Wilkinson SM, Love SB, Westcombe AM, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 1993; 25(5): 532-9.
[24]
Tao DJ. Research on the reduction of anxiety and depression with acupuncture. Am J Acupunct 1993; 21(4): 327-9.
[25]
Kessler RC, Soukup J, Davis RB, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 2001; 158(2): 289-94.
[http://dx.doi.org/10.1176/appi.ajp.158.2.289 PMID: 11156813]
[26]
Golden WL. Hypnotherapy for anxiety, phobias and psychophysiological disordersthe clinical use of hypnosis in cognitive behavior therapy: a practitioner’s casebook. Springer Publishing Company: United States 2006; pp. 101-37.
[27]
Dwivedi SK, Kotnala A. Impact of hypnotherapy in mitigating the symptoms of anxiety. Int J Psychol Psychiatry 2014; 2(2): 315.
[http://dx.doi.org/10.5958/2320-6233.2014.00017.0]
[28]
Ainsworth HR, Torgerson DJ, Torgerson CJ, et al. The effect of hypnotherapy on exam anxiety and exam performance: a pilot randomised controlled trial. Effective Education 2010; 2(2): 143-54.
[http://dx.doi.org/10.1080/19415532.2010.522799]
[29]
Golden WL. Cognitive-behavioral hypnotherapy for anxiety disorders. J Cogn Psychother 2018; 8(4): 265-74.
[http://dx.doi.org/10.1891/0889-8391.8.4.265]
[30]
Brown RP, Gerbarg PL. Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: part I-neurophysiologic model. J Altern Complement Med 2005; 11(1): 189-201.
[http://dx.doi.org/10.1089/acm.2005.11.189 ] [PMID: 15750381]
[31]
Anxiety T, Course YS. Effect of yoga intervention on anxiety and subjective well-being. J Indian Acad Appl Psychol 2009; 35(1): 27-31.
[32]
Smith C, Hancock H, Blake-Mortimer J, Eckert K. A randomised comparative trial of yoga and relaxation to reduce stress and anxiety. Complement Ther Med 2007; 15(2): 77-83.
[http://dx.doi.org/10.1016/j.ctim.2006.05.001 ] [PMID: 17544857]
[33]
Zhang L fang. Anxiety and thinking styles. Pers Individ Dif 2009; 47(4): 347-51.
[http://dx.doi.org/10.1016/j.paid.2009.04.001]
[34]
Berzen JL, Chadwick VF, Choi S, et al. Anxiolytic effect of exercise. Adapt Phys Activ Q 2018; 12: 187.
[35]
Lox CL. Ginis KAM Petruzzello SJ The Psychology of Exercise: Integrating theory and practice. Taylor & Francis: Philadelphia 2018; pp. 257-82.
[36]
Carek PJ, Laibstain SE, Carek SM. Exercise for the treatment of depression and anxiety. Int J Psychiatry Med 2011; 41(1): 15-28.
[http://dx.doi.org/10.2190/PM.41.1.c ] [PMID: 21495519]
[37]
Smits JAJ, Berry AC, Rosenfield D, Powers MB, Behar E, Otto MW. Reducing anxiety sensitivity with exercise. Depress Anxiety 2008; 25(8): 689-99.
[http://dx.doi.org/10.1002/da.20411 ] [PMID: 18729145]
[38]
Araújo SR, de Mello MT, Leite JR. [Anxiety disorders and physical exercise] Br J Psychiatry 2007; 29(2): 164-71.
[PMID: 17639256]
[39]
Heidary A, Emami A, Eskandaripour S, Saiah A, Hamidi S, Shahbazi M. Effects of aerobic exercise on anxiety. Procedia Soc Behav Sci 2011; 30: 2497-8.
[http://dx.doi.org/10.1016/j.sbspro.2011.10.487]
[40]
Charles RC, Robert ES. Modern Pharmacology with Clinical Applications. 5th ed. Philadelphia: Lippincott Williams & Wilkins, Wolters Kluwer Company 2004; p. 824.
[41]
Thakur P, Rana A. Anxiolytic potential of medicinal plants. Int J Nutr Pharmacol Neurol Dis 2013; 3(4): 325.
[http://dx.doi.org/10.4103/2231-0738.119838]
[42]
Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine 2000; 7(6): 463-9.
[http://dx.doi.org/10.1016/S0944-7113(00)80030-6 ] [PMID: 11194174]
[43]
Dhawan K, Kumar S, Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol 2001; 78(2-3): 165-70.
[http://dx.doi.org/10.1016/S0378-8741(01)00339-7 ] [PMID: 11694362]
[44]
Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001; 26(5): 363-7.
[http://dx.doi.org/10.1046/j.1365-2710.2001.00367.x ] [PMID: 11679026]
[45]
Rex A, Morgenstern E, Fink H. Anxiolytic-like effects of kava-kava in the elevated plus maze test-a comparison with diazepam. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26(5): 855-60.
[http://dx.doi.org/10.1016/S0278-5846(01)00330-X ] [PMID: 12369257]
[46]
Di Renzo G. Ginkgo biloba and the central nervous system. Fitoterapia 2000; 71(1)(Suppl. 1): S43-7.
[http://dx.doi.org/10.1016/S0367-326X(00)00180-5 ] [PMID: 10930712]
[47]
White HL, Scates PW, Cooper BR. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 1996; 58(16): 1315-21.
[http://dx.doi.org/10.1016/0024-3205(96)00097-5 ] [PMID: 8614288]
[48]
Kumar V, Jaiswal AK, Singh PN, Bhattacharya SK. Anxiolytic activity of Indian Hypericum perforatum Linn: an experimental study. Indian J Exp Biol 2000; 38(1): 36-41.
[PMID: 11233082]
[49]
Vandenbogaerde A, Zanoli P, Puia G, et al. Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats. Pharmacol Biochem Behav 2000; 65(4): 627-33.
[http://dx.doi.org/10.1016/S0091-3057(99)00233-6 ] [PMID: 10764915]
[50]
Dutt V, Dhar VJ, Sharma A. Antianxiety activity of Gelsemium sempervirens. Pharm Biol 2010; 48(10): 1091-6.
[http://dx.doi.org/10.3109/13880200903490521 PMID: 20860436]
[51]
Kumar D, Bhat ZA. Anti-anxiety activity of methanolic extracts of different parts of Angelica archangelica linn. J Tradit Complement Med 2012; 2(3): 235-41.
[http://dx.doi.org/10.1016/S2225-4110(16)30105-5 ] [PMID: 24716138]
[52]
Kumar D, Kumar S. Screening of anti anxiety activity of Abies pindrow royle aerial parts. Indian J Pharm Educ Res 2015; 49(1): 66-70.
[http://dx.doi.org/10.5530/ijper.49.1.9]
[53]
Kumar V, Singh RK, Jaiswal AK, Bhattacharya SK, Acharya SB. Anxiolytic activity of Indian Abies pindrow Royle leaves in rodents: an experimental study. Indian J Exp Biol 2000; 38(4): 343-6.
[PMID: 11218810]
[54]
Barua CC, Talukdar A, Begum SA, Borah P, Lahkar M. Anxiolytic activity of methanol leaf extract of Achyranthes aspera Linn in mice using experimental models of anxiety. Indian J Pharmacol 2012; 44(1): 63-7.
[http://dx.doi.org/10.4103/0253-7613.91869 ] [PMID: 22345872]
[55]
Madaan R, Sharma A. Anti-anxiety activity studies on various fractions of Actaea spicata Linn. J Pharm Biomed Sci 2010; 4(4): 1-4.
[56]
Halemani D, Geetha M, Shashikala G. Evaluation of anti anxiety activity of methanol extract of Aegle Marmelos (bael fruit tree) leaves in rats. IOSR J Dent Med Sci 2015; 14(9): 2279-861.
[57]
Kim WK, Jung JW, Ahn NY, et al. Anxiolytic-like effects of extracts from Albizzia julibrissin bark in the elevated plus-maze in rats. Life Sci 2004; 75(23): 2787-95.
[http://dx.doi.org/10.1016/j.lfs.2004.05.024 ] [PMID: 15464830]
[58]
Jung YH, Ha RR, Kwon SH, et al. Anxiolytic effects of Julibroside C1 isolated from Albizzia julibrissin in mice. Prog Neuropsychopharmacol Biol Psychiatry 2013; 44: 184-92.
[http://dx.doi.org/10.1016/j.pnpbp.2013.02.012 ] [PMID: 23481219]
[59]
Akindele AJ, Sanni HA, Edeh PC. Anxiolytic activity of aerial part hydroethanolic extract of Allium ascalonicum Linn. (Liliaceae) in mice. Funct Food Health Dis 2012; 2(11): 448-59.
[http://dx.doi.org/10.31989/ffhd.v2i11.71]
[60]
Gilhotra N, Dhingra D. GABAergic and nitriergic influence in antianxiety-like activity of garlic in mice. J Appl Pharm Sci 2016; 6(4): 77-85.
[http://dx.doi.org/10.7324/JAPS.2016.60411]
[61]
Kumar R, Jehan M, Sahu M. Evaluation of analgesic activity of lyophilized Aloe vera succulent in albino swiss mice. Indian J Appl Res 2014; 4(2): 413-5.
[62]
Arulmozhi S, Mazumder PM, Kangralkar VA, Narayanan LS, Thakurdesai P. Anti-Anxiety activity of Alstonia scholaris LINN. RBr Pharmacologyonline 2008; 3: 761-75.
[63]
Arulmozhi S, Mazumder PM, Sathiyanar L, Thakurdesa PA. Anti-anxiety and Anti-depressant Activity of Leaves of Alstonia scholaris Linn. RBr Pharmacologia 2012; 3(8): 239-48.
[http://dx.doi.org/10.5567/pharmacologia.2012.239.248]
[64]
Saha A, Bose S, Banerjee S. Anti-anxiety activity of Amorphophallus paeoniifolius tuber in mice. J Pharm Res 2013; 6(7): 748-52.
[http://dx.doi.org/10.1016/j.jopr.2013.07.018]
[65]
Grundmann O, Nakajima J, Seo S, Butterweck V. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol 2007; 110(3): 406-11.
[http://dx.doi.org/10.1016/j.jep.2006.09.035 ] [PMID: 17101250]
[66]
Grundmann O, Nakajima J, Kamata K, Seo S, Butterweck V. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice. Phytomedicine 2009; 16(4): 295-302.
[http://dx.doi.org/10.1016/j.phymed.2008.12.020 ] [PMID: 19303276]
[67]
Valcheva KS, Zhelyazkova SM. Anxiolytic-like effect of Aronia melanocarpa fruit juice in rats. Methods Find Exp Clin Pharmacol 2009; 31(10): 651.
[http://dx.doi.org/10.1039/C6FO00321D PMID: 27273205]
[68]
Tomic M. Ignjatovic DD Tovilovic- KG et al. Reduction of anxiety-like and depression-like behaviors in rats after one month of drinking: Aronia melanocarpa berry juice. Food Funct 2016; 7(7): 3111-20.
[69]
Jaiswal AK, Bhattacharya SK, Acharya SB. Anxiolytic activity of Azadirachta indica leaf extract in rats. Indian J Exp Biol 1994; 32(7): 489-91.
[PMID: 7959927]
[70]
Sujata KD, Kumar S. Central nervous system activity studies of Baptisia tinctoria (L.) R. Vent. Roots. Int J Pharmacol Phytochem Ethnomedicine 2017; 6: 1-7.
[http://dx.doi.org/10.18052/www.scipress.com/IJPPE.6.1]
[71]
Khare P. Deepshikha, Singh L, Sweety, Chauhan S, Yadav G. Evaluation of antianxiety activity of bauhinia variegata in mice. J Adv Res Pharm Biol Sci 2016; 2(2): 2-9.
[72]
Deepshikha KP, Singh L. Sweety, Chauhan S. Evaluation of antianxiety activity of bauhinia variegata by light-dark test of mice. Am J Toxicol Sci 2017; 8(4): 144-7.
[73]
Kaur D, Shri R, Kamboj A. Evaluation of anti-anxiety effect of Brassica oleracea L. extracts in experimental animals pharmacogn J 2017; 9(5): 638-43.
[74]
Ali A, Rao VN, Shalam M, Gouda ST, Babu J, Shantakumar S. 2007.
[75]
Singh J, Kumar A, Sharma A. Antianxiety activity guided isolation and characterization of bergenin from Caesalpinia digyna rottler roots. J Ethnopharmacol 2017; 195: 182-7.
[http://dx.doi.org/10.1016/j.jep.2016.11.016 ] [PMID: 27845264]
[76]
Rani A, Chander M. Pharmacological and phytochemical evaluation of Calendula officinalis linn. for anti-anxiety activity. Int J Pharmacogn Phytochem Res 2017; 9(1): 119-22.
[77]
Kharade S, Khetmar S, Desai P, Lokhande R, Patil S. Evaluation of anxiolytic activity of Carum copticum by using elevated plus maze and open field method. Int Res J Pharm 2011; 2(4): 165-8.
[78]
Shafeen S, Srinath Reddy T, Arafath S, Nagarjuna S, Padmanabha Reddy Y. Evaluation of antianxiety and antidepressant activity of Cassia occidentalis leaves. Asian J Pharm Clin Res 2012; 5(Suppl. 3): 47-50.
[79]
Katolkar P, Bhuskute S, Duragkar N. Evaluation of antianxiety and antidepressant activity of Cestrum nocturnum leaves. Int J Res Biosci Agric Technol 2015; 2(3): 232-6.
[80]
Sohrabi R, Pazgoohan N, Seresht HR, Amin B. Repeated systemic administration of the cinnamon essential oil possesses anti-anxiety and anti-depressant activities in mice. Iran J Basic Med Sci 2017; 20(6): 708-14.
[PMID: 28868126]
[81]
Gupta V, Bansal P, Kumar P, Shri R. Anxiolytic and antidepressant activities of different extracts from Citrus paradisi var. Duncan. Asian J Pharm Clin Res 2010; 3(2): 98-100.
[82]
Gupta V, Bansal P, Niazi J, Kaur G. Anti-anxiety activity of Citrus paradisi var. star ruby extracts. Int J Pharm Tech Res 2010; 2(3): 1655-7.
[83]
Gupta V. Development of economic herbal based drug substitute from Citrus paradisi (grape fruit) for existing anti-anxiety drug modules. Nat Prod Chem Res 2014; (1): 1-4.
[http://dx.doi.org/10.4172/2329-6836.S1-001]
[84]
Gupta V, Bansal P, Niazi J, Kohli K, Ghaiye P. 2016; Anti-anxiety activity of Citrus paradisi var. duncan extracts in swiss albino mice - a preclinical study. J Herb Med Res 2016; 1(1): 1-6.
[85]
Klungsupya P, Muangman T, Thisayakorn K, et al. Anti-anxiety Activity, Acute Toxicity and Cytotoxic Property of Extract of Clausena harmandiana (Pierre) Leaves. Isan J Pharm Sci 2015; 10: 199-206.
[86]
Lalitha KG, Sathish R, Gayathri R, et al. Pharmacological evaluation of Clerodendrum philippinum schauer flowers for antianxiety and central nervous system depressant activity. Int J Pharm Res 2010; 2(2): 13-5.
[87]
Kumar D, Dhobi M. Screening antianxiety and antioxidant profile of stems and leaves of blue variety of clitoria ternatea L. Indian J Pharm Sci 2017; 79(6): 1022-5.
[http://dx.doi.org/10.4172/pharmaceutical-sciences. 1000322]
[88]
Ishola IO, Chatterjee M, Tota S, et al. Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice. Pharmacol Biochem Behav 2012; 103(2): 322-31.
[http://dx.doi.org/10.1016/j.pbb.2012.08.017 ] [PMID: 22944105]
[89]
Jaikumar S, Sridhar V, Seetharaman A, Jayakumar P. Evaluation of anxiolytic activity of Commiphora wightii on experimental animal model. Int J Phytopharm 2016; 7(2): 89-91.
[90]
Mahendra P, Bisht S. Anti-anxiety activity of Coriandrum sativum assessed using different experimental anxiety models. Indian J Pharmacol 2011; 43(5): 574.
[PMID: 15619553]
[91]
Emamghoreishi M, Khasaki M, Aazam MF. Coriandrum sativum: evaluation of its anxiolytic effect in the elevated plus-maze. J Ethnopharmacol 2005; 96(3): 365-70.
[92]
Ravindran A, Manohar VR, Rai M, Raveendran N, Naik H. Chronic anxiolytic-like activity of aqueous extract of Coriandrum sativum seeds using elevated plus maze test in Swiss albino mice. Int J Pharm Pharm Sci 2014; 6(2): 93-5.
[93]
Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res 2009; 23(6): 768-74.
[http://dx.doi.org/10.1002/ptr.2597 ] [PMID: 19142981]
[94]
Costa CA, Kohn DO, de Lima VM, Gargano AC, Flório JC, Costa M. The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass). J Ethnopharmacol 2011; 137(1): 828-36.
[http://dx.doi.org/10.1016/j.jep.2011.07.003 ] [PMID: 21767622]
[95]
Shah G, Shiri R, Dhabiliya F, Nagpal N, Mann AS. Anti-anxiety activity of Cymbopogon citratus (DC.) stapf leaves extracts on the elevated plus-maze model of anxiety in mice. Pharmacogn J 2010; 2(15): 45-50.
[http://dx.doi.org/10.1016/S0975-3575(10)80078-1]
[96]
Ambavade SD, Mhetre NA, Muthal AP, Bodhankar SL. Anxiolytic activity of root extracts of Decalepis hamiltonii W.A. in mice. Pharmacologyonline 2008; 3: 306-15.
[97]
Rani VI, Kiranmai G, Pulla RP. Pharmacological evaluation of antianxiety activity of Desmostachya bipinnata leaves in animal models. Int J Curr Pharm Res 2017; 9(5): 152-4.
[98]
Hajhashemi V, Rabbani M, Ghanadi A, Davari E. Evaluation of antianxiety and sedative effects of essential oil of Ducrosia anethifolia in mice. Clinics (São Paulo) 2010; 65(10): 1037-42.
[http://dx.doi.org/10.1590/S1807-59322010001000020 ] [PMID: 21120308]
[99]
Rabbani M, Sajjadi SE, Vaseghi G, Jafarian A. Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice. Fitoterapia 2004; 75(5): 457-64.
[http://dx.doi.org/10.1016/j.fitote.2004.04.004 ] [PMID: 15261383]
[100]
Hosseinzadeh H, Shahandeh S, Shahsavand S. Anxiolytic and hypnotic effects of aqueous and ethanolic extracts of aerial parts of Echium italicum L. in mice. Jundishapur J Nat Pharm Prod 2012; 7(2): 71-9.
[http://dx.doi.org/10.5812/jjnpp.4589 PMID: 24624158]
[101]
Jena M, Mishra S. Sedative & antianxiety activity of ethanolic extract of Eclipta alba in albino rats. Int J Pharma Bio Sci 2013; 4(4): 1-8.
[102]
Singh B, Ishar MPS, Sharma A. Estimation of quercetin, an anxiolytic constituent, in Elaeocarpus ganitrus. J Pharmacogn Phytochem 2013; 1(6): 117-21.
[103]
Singh B, Sharma V, Sharma MPSI. Bioactivity guided isolation of quercetin as anxiolytic compound from Elaeocarpus ganitrus beads. Nat Prod J 2013; 3: 224-9.
[104]
Afzal M, Gupta G, Kazmi I, et al. Evaluation of anxiolytic activity of embelin isolated from Embelia ribes. Biomed Aging Pathol 2012; 2(2): 45-7.
[http://dx.doi.org/10.1016/j.biomag.2012.03.003]
[105]
Singh N, Kaur S, Bedi PMS, Kaur D. Anxiolytic effects of Equisetum arvense Linn. extracts in mice. Indian J Exp Biol 2011; 49(5): 352-6.
[PMID: 21615059]
[106]
Amin S, Bhat ZA. Evaluation of antianxiety and antioxidant activity of aerial parts and root of Eremurus himalaicus baker. Int J Res Pharm Chem 2017; 7(3): 264-72.
[107]
Santos Rosa D, Faggion SA, Gavin AS, et al. Erysothrine, an alkaloid extracted from flowers of Erythrina mulungu Mart. ex Benth: evaluating its anticonvulsant and anxiolytic potential. Epilepsy Behav 2012; 23(3): 205-12.
[http://dx.doi.org/10.1016/j.yebeh.2012.01.003 ] [PMID: 22381390]
[108]
Mesfin M, Asres K, Shibeshi W. Evaluation of anxiolytic activity of the essential oil of the aerial part of Foeniculum vulgare Miller in mice. BMC Complement Altern Med 2014; 14(1): 310.
[http://dx.doi.org/10.1186/1472-6882-14-310 ] [PMID: 25149087]
[109]
Naga KR, Anjaneyulu N, Naga GM, Sravya N. Evaluation of anxiolytic activity of ethanolic extract of Foeniculum vulgare in mice model. Int J Pharm Pharm Sci 2012; 4(Suppl. 3): 584-6.
[110]
Singh GK, Chauhan SK, Rai G, Chatterjee SS, Kumar V. Potential antianxiety activity of Fumaria indica: a preclinical study. Pharmacogn Mag 2013; 9(33): 14-22.
[http://dx.doi.org/10.4103/0973-1296.108129 ] [PMID: 23661988]
[111]
Singh R, Dhingra GS, Shri R. Evaluation of antianxiety potential of four Ganoderma (Agaricomycetes) species from India in mice. Int J Med Mushrooms 2016; 18(11): 991-8.
[112]
Jung JW, Yoon BH, Oh HR Ahn, et al. Anxiolytic like effects of Gastrodia elata and its phenolic constituents in mice. Biol Pharm Bull 2006; 29(2): 261-5.
[113]
Gahlot K, Abid M, Sharma A. Pharmacological evaluation of Gelsemium sempervirens roots for CNS depressant activity. Int J Pharm Tech Res 2011; 3(2): 693-7.
[114]
Sundaraganapathy R, Niraimathi V, Thangadurai A, Kamalakannan D, Narasimhan B, Deep A. Anti-anxiety activity of Gloriosa superba Linn. Hygeia J DMed 2013; 5(1): 148-51.
[115]
Kumar P, Madaan R, Sidhu S. Screening of antianxiety activity of Habenaria Intermedia D. Don Fruits. J Pharm Technol Res Manag 2017; 5(1): 71-5.
[116]
Walf AA, Frye CA. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 2005; 30(7): 1288-301.
[http://dx.doi.org/10.1038/sj.npp.1300708 PMID: 15756306]
[117]
Walf AA, Frye CA. Estradiol reduces anxiety- and depression-like behavior of aged female mice. Physiol Behav 2010; 99(2): 169-74.
[http://dx.doi.org/10.1016/j.physbeh.2009.09.017 ] [PMID: 19804793]
[118]
Walf AA, Frye CA. Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model. Gend Med 2009; 6(1): 300-11.
[http://dx.doi.org/10.1016/j.genm.2009.04.004 ] [PMID: 19467526]
[119]
Ordyan NE, Pivina SG, Akulova VK, Rakitskaya VV. Effects of prenatal stress and 17β-estradiol on anxiety and depressive behavior in ovariectomized female rats. Neurosci Behav Physiol 2014; 44(8): 871-8.
[http://dx.doi.org/10.1007/s11055-014-9995-1]
[120]
Subramania N, Jothimaniv C, Kumar RS, Kameshwara S. Evaluation of anti-anxiety activity of Justicia gendarussa burm. Pharmacologia 2013; 4(5): 404-7.
[http://dx.doi.org/10.5567/pharmacologia.2013.404.407]
[121]
Tiwari V, Singh A, Tiwari A. Evaluation of antidiabetic and antianxiety potential of Kalanchoe pinnata root standardized extracts. Egypt Pharm J 2017; 16(1): 24-36.
[http://dx.doi.org/10.4103/1687-4315.205830]
[122]
Chioca LR, Ferro MM, Baretta IP, et al. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission. J Ethnopharmacol 2013; 147(2): 412-8.
[http://dx.doi.org/10.1016/j.jep.2013.03.028 PMID: 23524167]
[123]
Bradley BF, Starkey NJ, Brown SL, Lea RW. Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze. J Ethnopharmacol 2007; 111(3): 517-25.
[http://dx.doi.org/10.1016/j.jep.2006.12.021 PMID: 17289317]
[124]
Souto-Maior FN, de Carvalho FLD, de Morais LCSL, Netto SM, de Sousa DP, de Almeida RN. Anxiolytic-like effects of inhaled linalool oxide in experimental mouse anxiety models. Pharmacol Biochem Behav 2011; 100(2): 259-63.
[http://dx.doi.org/10.1016/j.pbb.2011.08.029 PMID: 21925533]
[125]
Razavi BM, Zargarani N, Hosseinzadeh H. Anti anxiety and hypnotic effects of ethanolic and aqueous extracts of Lippia citriodora leaves and verbascoside in mice. Avicenna J Phytomed 2017; 7(4): 353-65.
[PMID: 28884085]
[126]
Kaur S, Sharma A, Bedi PMS. Evaluation of anxiolytic effect of Melilotus officinalis extracts in mice. Asian J Pharm Clin Res 2017; 10(6): 396.
[http://dx.doi.org/10.22159/ajpcr.2017.v10i6.17183]
[127]
Bora KS, Dubey A. Evaluation of anti-anxiety activity of Melissa parviflora (Benth.) in rats. Thaiphesatchasan 2015; 39(3): 70-5.
[128]
Doukkali Z, Rabie K, Jemeli ME, et al. Anti-anxiety effects of Mercurialis annua aqueous extract in the elevated plus maze test Pharm Bioprocess 2016.; 4(4): 056-61.
[129]
Lakshmi BVS, Sudhakar M, Ramya RLV. Anti-anxiety activity of Moringa oliefera assessed using different experimental anxiety models in mice. J Pharm Res 2014; 8(3): 343-8.
[130]
Bhat SK, Joy AE. Antianxiety effect of ethanolic extract of leaves of Moringa oleifera in Swiss albino mice. Arch Med Heal Sci 2014; 2(1): 5-7.
[http://dx.doi.org/10.4103/2321-4848.133771]
[131]
Bhattacharya A, Santra S, Mahapatra S, Sahu P, Agrawal D, Kumar S. Study of anxiolytic effect of ethanolic extract of drumstick tree leaves on albino mice in a basic neuropharmacology laboratory of a postgraduate teaching institute. J Heal Res Rev 2016; 3(2): 41-7.
[http://dx.doi.org/10.4103/2394-2010.184228]
[132]
Sachan A, Kumar S, Singh H, et al. Potential anti-anxiety effect of Mucuna pruriens in experimental model of swiss albino mice. PTB Reports 2015; 1(1): 20-3.
[http://dx.doi.org/10.5530/PTB.1.1.7]
[133]
Singh S, Gupta P, Gupta R. Evaluation of anti-anxiety activity of Mucuna pruriens. J Drug Deliv Ther 2019; 9(4-A): 104-7.
[http://dx.doi.org/10.22270/jddt.v9i4-A.3420]
[134]
Saravanan S, Manokaran S, Chand S. Anxiolytic activity of hydro-alcoholic extract of Mukia maderaspatana linn. leaves on experimental animals. Jordan J Pharm Sci 2012; 5(1): 43-50.
[135]
Sharma S, Handu S, Dubey AK, Sharma P, Mediratta P, Ahmed QM. Anti-anxiety and anti-depressant like effects of Murraya koenigii in experimental models of anxiety and depression. Anc Sci Life 2017; 36(4): 215-9.
[http://dx.doi.org/10.4103/asl.ASL_75_17 PMID: 29269974]
[136]
Sharma P, Batra S, Kumar A, Sharma A. In vivo antianxiety and antidepressant activity of Murraya paniculata leaf extracts. J Integr Med 2017; 15(4): 320-5.
[http://dx.doi.org/10.1016/S2095-4964(17)60352-2 ] [PMID: 28659237]
[137]
Taïwe GS, Ngo Bum E, Dimo T, et al. Antidepressant, myorelaxant and anti-anxiety-like effects of Nauclea latifolia Smith (Rubiaceae) roots extract in murine models. Int J Pharmacol 2010; 6(4): 326-33.
[http://dx.doi.org/10.3923/ijp.2010.364.371]
[138]
Ngo Bum E, Taiwe GS, Moto FCO, et al. Anticonvulsant, anxiolytic, and sedative properties of the roots of Nauclea latifolia smith in mice. Epilepsy Behav 2009; 15(4): 434-40.
[http://dx.doi.org/10.1016/j.yebeh.2009.05.014 ] [PMID: 19560975]
[139]
Prasad DK, Sriharsha SN. Evaluation of anxiolytic activity of leaf extracts of Nelumbo nucifera in laboratory rodents. Int J Pharma Bio Sci 2015; 5(4): 24-30.
[PMID: 28144887]
[140]
Rajput MA, Khan RA. Phytochemical screening, acute toxicity, anxiolytic and antidepressant activities of the Nelumbo nucifera fruit. Metab Brain Dis 2017; 32(3): 743-9.
[141]
Kulkarni MP, Juvekar AR. Anti-anxiety effects of leaves of Nelumbo nucifera gaertn. in mice. Pharmacologyonline 2009; 2: 292-9.
[142]
dela PIJI Hong E dela PJB et al. Milk collected at night induces sedative and anxiolytic-like effects and augments pentobarbital-induced sleeping behavior in mice. J Med Food 2015; 18(11): 1255-61.
[143]
Tripathi S, Tripathi PK, Vijayakumar M, Rao CV, Singh PN. Anxiolytic activity of leaf extract of Nyctanthes arbortristis in experimental rats. Pharmacologyonline 2010; 2: 457-63.
[144]
Rabbani M, Sajjadi SE, Vaezi A. Evaluation of anxiolytic and sedative effect of essential oil and hydroalcoholic extract of Ocimum sanctum L. and chemical composition of its essential oil. Res Pharm Sci 2015; 10(6): 535-43.
[PMID: 26779273]
[145]
Chattopadhyay RR. Anxiolytic activity of Ocimum sanctum leaf extract. Anc Sci Life 1994; 14(1-2): 108-11.
[PMID: 22556686]
[146]
Manu G, Padmanabha S, Chandrakantha T, Ravishankar M. Evaluation of antianxiety activity of ethanolic extract of leaves of Ocimum sanctum (tulsi) in albino mice. Natl J Physiol Pharm Pharmacol 2017; 7(8): 827-30.
[http://dx.doi.org/10.5455/njppp.2017.7.0411310042017]
[147]
de Castro PCF, Hoshino A, da Silva JC, Mendes FR. Possible anxiolytic effect of two extracts of Passiflora quadrangularis L. in experimental models. Phytother Res 2007; 21(5): 481-4.
[http://dx.doi.org/10.1002/ptr.2079 ] [PMID: 17295387]
[148]
Deng J, Zhou Y, Bai M, Li H, Li L. Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa. J Ethnopharmacol 2010; 128(1): 148-53.
[http://dx.doi.org/10.1016/j.jep.2009.12.043 ] [PMID: 20051259]
[149]
Li H, Zhou P, Yang Q, et al. Comparative studies on anxiolytic activities and flavonoid compositions of Passiflora edulis ‘edulis’ and Passiflora edulis ‘flavicarpa’. J Ethnopharmacol 2011; 133(3): 1085-90.
[http://dx.doi.org/10.1016/j.jep.2010.11.039 ] [PMID: 21111038]
[150]
Dhawan K, Kumar S, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia 2001; 72(8): 922-6.
[http://dx.doi.org/10.1016/S0367-326X(01)00322-7 ] [PMID: 11731118]
[151]
Dhawan K, Kumar S, Sharma A. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata linneaus: a comment on medicinal plants’ standardization. J Altern Complement Med 2002; 8(3): 283-91.
[http://dx.doi.org/10.1089/10755530260127970 ] [PMID: 12165186]
[152]
Reginatto FH, De-Paris F, Petry RD, et al. Evaluation of anxiolytic activity of spray dried powders of two South Brazilian Passiflora species. Phytother Res 2006; 20(5): 348-51.
[http://dx.doi.org/10.1002/ptr.1853 ] [PMID: 16619361]
[153]
Grundmann O, Wähling C, Staiger C, Butterweck V. Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice. Pharmazie 2009; 64(1): 63-4.
[PMID: 19216234]
[154]
Aslanargun P, Cuvas O, Dikmen B, Aslan E, Yuksel MU. Passiflora incarnata Linneaus as an anxiolytic before spinal anesthesia. J Anesth 2012; 26(1): 39-44.
[http://dx.doi.org/10.1007/s00540-011-1265-6 ] [PMID: 22048283]
[155]
Sampath C, Holbik M, Krenn L, Butterweck V. Anxiolytic effects of fractions obtained from Passiflora incarnata L. in the elevated plus maze in mice. Phytother Res 2011; 25(6): 789-95.
[http://dx.doi.org/10.1002/ptr.3332 ] [PMID: 21077264]
[156]
Dhawan K, Kumar S, Sharma A. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata Linneaus: a comment on medicinal plants’ standardization. J Altern Complement Med 2002; 8(3): 283-91.
[157]
Grundmann O, Wang J, McGregor GP, Butterweck V. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med 2008; 74(15): 1769-73.
[http://dx.doi.org/10.1055/s-0028-1088322 PMID: 19006051]
[158]
Elsas SM, Rossi DJ, Raber J, et al. Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine 2010; 17(12): 940-9.
[http://dx.doi.org/10.1016/j.phymed.2010.03.002 ] [PMID: 20382514]
[159]
Gamberini MT, Rodrigues DS, Rodrigues D, Pontes VB. Effects of the aqueous extract of Pimpinella anisum L. seeds on exploratory activity and emotional behavior in rats using the open field and elevated plus maze tests. J Ethnopharmacol 2015; 168: 45-9.
[http://dx.doi.org/10.1016/j.jep.2015.03.053 ] [PMID: 25839118]
[160]
Garrett KM, Basmadjian G, Khan IA, Schaneberg BT, Seale TW. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice. Psychopharmacology (Berl) 2003; 170(1): 33-41.
[http://dx.doi.org/10.1007/s00213-003-1520-0 ] [PMID: 12845414]
[161]
Feltenstein MW, Lambdin LC, Ganzera M, et al. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. Phytother Res 2003; 17(3): 210-6.
[http://dx.doi.org/10.1002/ptr.1107 ] [PMID: 12672148]
[162]
Tiwari DK, Nagar H, Dwivedi G, Tripathi RK, Jena J. Evaluation of anti-anxiety activity of Plectranthus amboinicus (Lour.) on rats. Asian J Pharm Clin Res 2012; 5(Suppl. 4): 110-3.
[163]
Kaur G, Singh S, Goyal S, Sharma B, Siddiqui A, Mishra R. Phytochemical investigation and evaluation of anti-anxiety activity on Psidium guajava Linn. leaf. World J Pharm Pharm Sci 2017; 6(1): 1332-41.
[164]
Das S, Sarma P. A study on the anticonvulsant and antianxiety activity of ethanolic extract of Punica granatum Linn. Int J Pharm Pharm Sci 2014; 6(2): 389-92.
[165]
Rabbani M, Sajjadi SE, Jafarian A, Vaseghi G. Anxiolytic effects of Salvia reuterana Boiss. on the elevated plus-maze model of anxiety in mice. J Ethnopharmacol 2005; 101(1-3): 100-3.
[http://dx.doi.org/10.1016/j.jep.2005.03.034 ] [PMID: 15994042]
[166]
Korah MC, Puthanvalappil JR, Sheik HS, Lalitha V, Sringaravel S, Thangavel SK. Antianxiety activity of ethanolic extract of Sapindus emarginatus flowers in experimental animal models. Int J Pharm Chemiical Bioligical Sci 2015; 5(4): 790-5.
[167]
Chakraborty A, Amudha P, Geetha M, Surjit Singh N. Evaluation of anxiolytic activity of methanolic extract of Sapindus mukorossi Gaertn. in mice. Int J Pharma Bio Sci 2010; 1(3): 1-8.
[168]
Ambavade SD, Mhetre NA, Patil KM, Desai T, Bodhankar SL. Anxiolytic activity of root extracts of Saussurialappa Clark. in mice. J Nat Rem 2006; 6(2)
[169]
Elayaraja A, Rahaman SA, Kumar PP, Krishnan MR. Anti-anxiety activity of hydro alcoholic extract of Scoparia dulcis Linn. assessed using different experimental anxiety models in rodents. Int J Pharmacol Res 2015; 5(3): 62-7.
[170]
Mohan M, Attarde D, Momin R, Kasture S. Antidepressant, anxiolytic and adaptogenic activity of torvanol A: an isoflavonoid from seeds of Solanum torvum. Nat Prod Res 2013; 27(22): 2140-3.
[http://dx.doi.org/10.1080/14786419.2013.778853 ] [PMID: 23521182]
[171]
Meti V, Dabburu K. Anti-anxiety activity of ethanolic extract of Spermacoce hispida leaves in swiss albino mice. Int J Basic Clin Pharmacol 2017; 6(9): 2224-7.
[PMID: 26069368]
[172]
Sharma H, Garg M. Neuropharmacological activities of Taxus wallichiana bark in Swiss albino mice. Indian J Pharmacol 2015; 47(3): 299-303.
[173]
Bhandari SS, Kabra MP. To evaluate anti-anxiety activity of thymol. J Acute Dis 2014; 3(2): 136-40.
[http://dx.doi.org/10.1016/S2221-6189(14)60030-5]
[174]
Kumar S, Sharma A. Anti-Anxiety activity studies of various extracts of Turnera aphrodisiaca. Ward J Herb Pharmacother 2006; 5(4): 13-21.
[http://dx.doi.org/10.1093/ecam/neh069]
[175]
Kumar S, Sharma A. Anti-anxiety activity studies on homoeopathic formulations of Turnera aphrodisiaca Evid. Based Complementary Altern Med 2005; 2(1): 117-9.
[176]
Manikkoth S, Chandrashekar R, Rao SN. Antianxiety effect of ethanolic extract of leaves of Tylophora indica in wistar albino rats. Int J Res Ayurveda Pharm 2013; 4(1): 127-9.
[http://dx.doi.org/10.7897/2277-4343.04142]
[177]
Jung JW, Ahn NY, Oh HR, et al. Anxiolytic effects of the aqueous extract of Uncaria rhynchophylla. J Ethnopharmacol 2006; 108(2): 193-7.
[http://dx.doi.org/10.1016/j.jep.2006.05.019 ] [PMID: 16829000]
[178]
Bhandarkar AV, Shashidhara S, Deepak M. Comparative anxiolytic activity of petroleum extract of Valeriana jatamansi from different accessions in mice. Res Rev J Pharmacol Toxicol Stud 2014; 2(2): 34-9.
[179]
Chowta M, Maskeri R, Rai A, Shoeb A, Venkatesh V, Bhagwat V. Evaluation of anxiolytic activity of vanillin in wistar albino rats. Int J Nutr Pharmacol Neurol Dis 2013; 3(2): 96.
[http://dx.doi.org/10.4103/2231-0738.112828]
[180]
Adnaik R, Pai P, Sapakal V, Naikwade N, Magdum C. Anxiolytic activity of Vitex negundo linn. in experimental models of anxiety in mice. Int J Green Pharm 2009; 3(3): 243-7.
[http://dx.doi.org/10.4103/0973-8258.56284]
[181]
Sharma A. Gulsheen, Kumar A, Sharma A. Comparative anti-anxiety potential of different parts of vitex negundo linn. Int J Pharm Sci Res 2018; 9(1): 282-5.
[182]
Kim TE, Jung JH, Yoon S, Kim SJ. Anti-anxiety effect of methanol extract of Pericarpium zanthoxyli using a strychnine-sensitive glycine receptor model. Trop J Pharm Res 2016; 15(5): 951-7.
[http://dx.doi.org/10.4314/tjpr.v15i5.8]
[183]
Gupta K, Ravishankar B, Ashok B, Thakar A. Anti-anxiety and anti-depressant activities of Sarasvata choorna in experimental animals. Ayu 2011; 32(4): 590-3.
[184]
Toolika E Ravi M Narayana PB Shetty SK Ravishankar B Savitha H. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia) w.s.r. to primary insomnia J Phytopharm 2015; 4(3): 147-51.
[185]
Toolika E, Bhat NP, Shetty SK. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia). Ayu 2015; 36(1): 46-9.
[http://dx.doi.org/10.4103/0974-8520.169008 ] [PMID: 26730138]
[186]
Bhatt C, Kanaki N, Nayak R, Shah G. Synergistic potentiation of anti-anxiety activity of valerian and alprazolam by liquorice. Indian J Pharmacol 2013; 45(2): 202-3.
[http://dx.doi.org/10.4103/0253-7613.108328 ] [PMID: 23716906]
[187]
Kumar A, Singh J, Sharma A. Comparative antianxiety activity evaluation of Argyreia speciosa Linn. (Roots), Caesalpinia digyna Rottler (Roots) and Sphaeranthus indicus Linn. (flowers). Int J Pharm Sci Res 2015; 6(10): 4226-9.
[188]
Dhawan K, Kumar S, Sharma A. Comparative biological activity study on Passiflora incarnata and P. edulis. Fitoterapia 2001; 72(6): 698-702.
[http://dx.doi.org/10.1016/S0367-326X(01)00306-9 ] [PMID: 11543974]
[189]
Abid M, Gosh AK, Khan NA. In vivo psychopharmacological investigation of Delphinium denudatum and Amaranthus spinosus extracts on Wistar Rats. Basic Clin Neurosci 2017; 8(6): 503-12.
[http://dx.doi.org/10.29252/nirp.bcn.8.6.503 PMID: 29942433]
[190]
Sharma MC, Sharma S, Kohli DV. Combined effect of anti-inflammatory and anti-anxiety, analgesic activity of herbal formulation using medicinal ethanolic extract leaves. J Optoelectron Biomed Mater 2009; 1(4): 315-8.
[191]
Babu VD, Kulkarni R, George J. Study on Anti anxiety activity of ALERT - a poly herbal formulation in Experimental animal models. Int J Allied Med Sci Clin Res 2017; 5(2): 368-78.
[192]
Krishna HNG, Sangha RB, Misra N, Pai MRSM. Antianxiety activity of NR-ANX-C, a polyherbal preparation in rats. Indian J Pharmacol 2006; 38(5): 330-5.
[http://dx.doi.org/10.4103/0253-7613.27700]
[193]
Nair V, Mohan L, Rao USC, Gopalakrishna HN. Evaluation of the anxiolytic activity of NR-ANX-C (a Polyherbal Formulation) in ethanol withdrawal induced anxiety behavior in rats. Evid Based Complement Altern Med 2011 2011.
[194]
Bhattacharya SK. Behavioural studies on BR-16A (Mentat), a herbal psychotropic formulation. Indian J Exp Biol 1994; 32(1): 37-43.
[PMID: 8045603]
[195]
Kumar AA, Reddy KKP. Anxiolytic profile of a polyherbal profile of a polyherbal drug Mentat. Int J Pharm Med Bio Sci 2013; 2(4): 21-7.
[196]
Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies. CNS Drugs 2013; 27(3): 207-19.
[http://dx.doi.org/10.1007/s40263-013-0044-3 ] [PMID: 23436255]
[197]
Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. CNS Drugs 2013; 27(4): 301-19.
[http://dx.doi.org/10.1007/s40263-013-0059-9 PMID: 23653088]
[198]
Charles PD, Ambigapathy G, Geraldine P, Akbarsha MA, Rajan KE. Bacopa monniera leaf extract up-regulates tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression: implications in memory formation. J Ethnopharmacol 2011; 134(1): 55-61.
[http://dx.doi.org/10.1016/j.jep.2010.11.045 PMID: 21129470]
[199]
Pase MP, Kean J, Sarris J, Neale C, Scholey AB, Stough C. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. J Altern Complement Med 2012; 18(7): 647-52.
[http://dx.doi.org/10.1089/acm.2011.0367 PMID: 22747190]
[200]
Platel A, Carpentier R, Becart E, et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. N Engl J Med 2017; 216(6): 1833-42.
[201]
Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2001; 156(4): 481-4.
[http://dx.doi.org/10.1007/s002130100815 PMID: 11498727]
[202]
Stough C, Lloyd J, Clarke J, et al. Erratum to: The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2015; 232(13): 2427-7.
[http://dx.doi.org/10.1007/s00213-015-3965-3 ] [PMID: 26032841]
[203]
Bradwejn J, Zhou Y, Koszycki D, Shlik J. A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol 2000; 20(6): 680-4.
[http://dx.doi.org/10.1097/00004714-200012000-00015 ] [PMID: 11106141]
[204]
Chen Y, Han T, Rui Y, Yin M, Qin L, Zheng H. [Effects of total triterpenes of Centella asiatica on the corticosterone levels in serum and contents of monoamine in depression rat brain] Zhong Yao Cai 2005; 28(6): 492-6.
[PMID: 16209267]
[205]
Jana U, Sur TK, Maity LN, Debnath PK, Bhattacharyya D. A clinical study on the management of generalized anxiety disorder with Centella asiatica. Nepal Med Coll J 2010; 12(1): 8-11.
[PMID: 20677602]
[206]
Wijeweera P, Arnason JT, Koszycki D, Merali Z. Evaluation of anxiolytic properties of Gotukola--(Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine 2006; 13(9-10): 668-76.
[http://dx.doi.org/10.1016/j.phymed.2006.01.011 ] [PMID: 16488124]
[207]
Campos AC, Guimarães FS. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl) 2008; 199(2): 223-30.
[http://dx.doi.org/10.1007/s00213-008-1168-x ] [PMID: 18446323]
[208]
Resstel LBM, Tavares RF, Lisboa SFS, Joca SRL, Corrêa FMA, Guimarães FS. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol 2009; 156(1): 181-8.
[http://dx.doi.org/10.1111/j.1476-5381.2008.00046.x ] [PMID: 19133999]
[209]
Bergamaschi MM, Queiroz RHC, Chagas MHN, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology 2011; 36(6): 1219-26.
[http://dx.doi.org/10.1038/npp.2011.6 PMID: 21307846]
[210]
Saiyudthong S, Marsden CA. Acute effects of bergamot oil on anxiety-related behaviour and corticosterone level in rats. Phytother Res 2011; 25(6): 858-62.
[http://dx.doi.org/10.1002/ptr.3325 ] [PMID: 21105176]
[211]
Akhlaghi M, Shabanian G, Rafieian-Kopaei M, Parvin N, Saadat M, Akhlaghi M. Citrus aurantium blossom and preoperative anxiety. Rev Bras Anestesiol 2011; 61(6): 702-12.
[http://dx.doi.org/10.1016/S0034-7094(11)70079-4 ] [PMID: 22063371]
[212]
Sayyah M, Boostani H, Pakseresht S, Malaieri A. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(8): 1513-6.
[http://dx.doi.org/10.1016/j.pnpbp.2009.08.021 ] [PMID: 19737592]
[213]
Herrera-Ruiz M, González-Cortazar M, Jiménez-Ferrer E, et al. Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivatives. J Nat Prod 2006; 69(1): 59-61.
[http://dx.doi.org/10.1021/np050305x PMID: 16441069]
[214]
Herrera RM, Gonzalez CM, Jimenez FE, et al. Erratum in: Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivatives. J Nat Prod 2007; 70(12): 2054.
[215]
Herrera-Ruiz M, Jiménez-Ferrer JE, De Lima TCM, et al. Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca. Phytomedicine 2006; 13(1-2): 23-8.
[http://dx.doi.org/10.1016/j.phymed.2005.03.003 ] [PMID: 16360929]
[216]
Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam. Planta Med 2007; 73(8): 713-7.
[http://dx.doi.org/10.1055/s-2007-981539 PMID: 17562493]
[217]
Herrera-Arellano A, Jiménez-Ferrer JE, Zamilpa A, García-Alonso G, Herrera-Alvarez S, Tortoriello J. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial. Planta Med 2012; 78(14): 1529-35.
[http://dx.doi.org/10.1055/s-0032-1315110 PMID: 22828921]
[218]
Jiménez-Ferrer E, Herrera-Ruiz M, Ramírez-García R, Herrera-Arellano A, Tortoriello J. Interaction of the natural anxiolytic Galphimine-B with serotonergic drugs on dorsal hippocampus in rats. J Ethnopharmacol 2011; 137(1): 724-9.
[http://dx.doi.org/10.1016/j.jep.2011.06.029 PMID: 21742023]
[219]
Yoshitake T, Yoshitake S, Kehr J. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 2010; 159(3): 659-68.
[http://dx.doi.org/10.1111/j.1476-5381.2009.00580.x ] [PMID: 20105177]
[220]
Fehske CJ, Leuner K, Müller WE. Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol Res 2009; 60(1): 68-73.
[http://dx.doi.org/10.1016/j.phrs.2009.02.012 ] [PMID: 19427589]
[221]
Kuribara H, Weintraub ST, Yoshihama T, Maruyama Y. An anxiolytic-like effect of Ginkgo biloba extract and its constituent, ginkgolide-A, in mice. J Nat Prod 2003; 66(10): 1333-7.
[http://dx.doi.org/10.1021/np030122f PMID: 14575433]
[222]
Woelk H, Arnoldt KH, Kieser M, Hoerr R. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res 2007; 41(6): 472-80.
[http://dx.doi.org/10.1016/j.jpsychires.2006.05.004 ] [PMID: 16808927]
[223]
Butterweck V, Schmidt MSt. John’s wort: role of active compounds for its mechanism of action and efficacy. Wien Med Wochenschr 2007; 157(13-14): 356-61.
[http://dx.doi.org/10.1007/s10354-007-0440-8 ] [PMID: 17704987]
[224]
Nathan PJ. Hypericum perforatum (St John’s Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology. J Psychopharmacol (Oxford) 2001; 15(1): 47-54.
[http://dx.doi.org/10.1177/026988110101500109 ] [PMID: 11277608]
[225]
Taylor LH, Kobak KA. An open-label trial of St. John’s Wort (Hypericum perforatum) in obsessive-compulsive disorder. J Clin Psychiatry 2000; 61(8): 575-8.
[http://dx.doi.org/10.4088/JCP.v61n0806 PMID: 10982200]
[226]
Kobak KA, Taylor LVH, Bystritsky A, et al. St John’s wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Int Clin Psychopharmacol 2005; 20(6): 299-304.
[http://dx.doi.org/10.1097/00004850-200511000-00003 ] [PMID: 16192837]
[227]
Kobak KA, Taylor LVH, Warner G, Futterer RSt. John’s wort versus placebo in social phobia: results from a placebo-controlled pilot study. J Clin Psychopharmacol 2005; 25(1): 51-8.
[http://dx.doi.org/10.1097/01.jcp.0000150227.61501.00 ] [PMID: 15643100]
[228]
Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol 2009; 29(4): 378-82.
[http://dx.doi.org/10.1097/JCP.0b013e3181ac935c ] [PMID: 19593179]
[229]
Viola H, Wasowski C, Levi de Stein M, et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 1995; 61(3): 213-6.
[http://dx.doi.org/10.1055/s-2006-958058 PMID: 7617761]
[230]
Mao JJ, Li QS, Soeller I, Rockwell K, Xie SX, Amsterdam JD. Long-term chamomile therapy of generalized anxiety disorder: a study protocol for a randomized, double-blind, placebo-controlled trial. J Clin Trials 2014; 4(5): 188.
[PMID: 29057164]
[231]
Zanoli P, Avallone R, Baraldi M. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia 2000; 71(Suppl. 1): S117-23.
[http://dx.doi.org/10.1016/S0367-326X(00)00186-6 ] [PMID: 10930722]
[232]
Mao J. Long-term chamomile for generalized anxiety disorder: a randomized controlled trial. J Altern Complement Med 2016; 22(6): A59.
[233]
Cases J, Ibarra A, Feuillère N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab 2011; 4(3): 211-8.
[http://dx.doi.org/10.1007/s12349-010-0045-4 ] [PMID: 22207903]
[234]
Awad R, Muhammad A, Durst T, Trudeau VL, Arnason JT. Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother Res 2009; 23(8): 1075-81.
[http://dx.doi.org/10.1002/ptr.2712 ] [PMID: 19165747]
[235]
Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg 2008; 106(6): 1728-32.
[http://dx.doi.org/10.1213/ane.0b013e318172c3f9 ] [PMID: 18499602]
[236]
Azimaraghi O, Yousefshahi F, Khatavi F, Zamani MM, Movafegh A. Both oral Passiflora incarnata and oxazepam can reduce pre-operative anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Asian J Pharm Clin Res 2017; 10(8): 331-4.
[http://dx.doi.org/10.22159/ajpcr.2017.v10i8.18852]
[237]
Sarris J, Stough C, Bousman CA, et al. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol 2013; 33(5): 643-8.
[http://dx.doi.org/10.1097/JCP.0b013e318291be67 ] [PMID: 23635869]
[238]
Boerner RJ. Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia. Phytother Res 2001; 15(7): 646-7.
[http://dx.doi.org/10.1002/ptr.1006 ] [PMID: 11746854]
[239]
Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev 2003; (1): 1-21.
[PMID: 12535473]
[240]
Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010; 17(7): 481-93.
[http://dx.doi.org/10.1016/j.phymed.2010.02.002 ] [PMID: 20378318]
[241]
Perfumi M, Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 2007; 21(1): 37-43.
[http://dx.doi.org/10.1002/ptr.2013 ] [PMID: 17072830]
[242]
Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med 2008; 14(2): 175-80.
[http://dx.doi.org/10.1089/acm.2007.7117 PMID: 18307390]
[243]
Cayer C, Ahmed F, Filion V, et al. Characterization of the anxiolytic activity of Nunavik Rhodiola rosea. Planta Med 2013; 79(15): 1385-91.
[http://dx.doi.org/10.1055/s-0033-1350709 PMID: 23975866]
[244]
Hosseinzadeh H, Danaee A, Ziaee T. Anti-anxiety effect of aqueous and ethanolic extracts of Salvia leriifolia Benth. leaves in mice using elevated plus maze. J Med Plants 2008; 7(27): 25-36.
[245]
Maione F, Bonito MC, Colucci M, et al. First evidence for an anxiolytic effect of a diterpenoid from Salvia cinnabarina. Nat Prod Commun 2009; 4(4): 469-72.
[http://dx.doi.org/10.1177/1934578X0900400404 ] [PMID: 19475986]
[246]
Kennedy DO, Dodd FL, Robertson BC, et al. Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. J Psychopharmacol (Oxford) 2011; 25(8): 1088-100.
[http://dx.doi.org/10.1177/0269881110385594 ] [PMID: 20937617]
[247]
Herrera-Ruiz M, García-Beltrán Y, Mora S, et al. Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J Ethnopharmacol 2006; 107(1): 53-8.
[http://dx.doi.org/10.1016/j.jep.2006.02.003 PMID: 16530995]
[248]
Mora S, Millán R, Lungenstrass H, et al. The hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in rats. J Ethnopharmacol 2006; 106(1): 76-81.
[http://dx.doi.org/10.1016/j.jep.2005.12.004 PMID: 16413718]
[249]
Naderi N, Akhavan N, Aziz Ahari F, et al. Effects of hydroalcoholic extract from Salvia verticillata on pharmacological models of seizure, anxiety and depression in mice. Iran J Pharm Res 2011; 10(3): 535-45.
[PMID: 24250386]
[250]
Perry NSL, Houghton PJ, Sampson J, et al. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer’s disease. J Pharm Pharmacol 2001; 53(10): 1347-56.
[http://dx.doi.org/10.1211/0022357011777846 ] [PMID: 11697542]
[251]
Awad R, Arnason JT, Trudeau V, et al. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine 2003; 10(8): 640-9.
[http://dx.doi.org/10.1078/0944-7113-00374 ] [PMID: 14692724]
[252]
Li J, Wang YH, Smillie TJ, Khan IA. Identification of phenolic compounds from Scutellaria lateriflora by liquid chromatography with ultraviolet photodiode array and electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 2012; 63: 120-7.
[http://dx.doi.org/10.1016/j.jpba.2012.01.027 ] [PMID: 22342658]
[253]
Zhang Z, Lian XY, Li S, Stringer JL. Characterization of chemical ingredients and anticonvulsant activity of American skullcap (Scutellaria lateriflora). Phytomedicine 2009; 16(5): 485-93.
[http://dx.doi.org/10.1016/j.phymed.2008.07.011 ] [PMID: 18786819]
[254]
Kuroda M, Iwabuchi K, Mimaki Y. Chemical constituents of the aerial parts of Scutellaria lateriflora and their α-glucosidase inhibitory activities. Nat Prod Commun 2012; 7(4): 471-4.
[http://dx.doi.org/10.1177/1934578X1200700413 ] [PMID: 22574444]
[255]
Yaghmai MS. Volatile constituents of Scutellaria lateriflora L. Flavour Fragrance J 1988; 3(1): 27-31.
[http://dx.doi.org/10.1002/ffj.2730030106]
[256]
Wolfson P, Hoffmann DL. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med 2003; 9(2): 74-8.
[PMID: 12652886]
[257]
Sayyah M, Boostani H, Pakseresht S, Malayeri A. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(2): 362-5.
[http://dx.doi.org/10.1016/j.pnpbp.2009.12.016 ] [PMID: 20035818]
[258]
Osuchowski MF, Johnson VJ, He Q, Sharma RP. Alterations in regional brain neurotransmitters by silymarin, a natural antioxidant flavonoid mixture, in BALB/c mice. Pharm Biol 2004; 42(4-5): 384-9.
[http://dx.doi.org/10.1080/13880200490519712]
[259]
Zhai X, Kong ZY, Wang SJ, et al. Study on anti-anxiety activity of extract and total valepotriate in Valerianae Rhizoma Chinese Tradit Herb Drugs 2016; (8): 1361-5..
[260]
Bhattacharyya D, Jana U, Debnath PK, Sur TK. Initial exploratory observational pharmacology of Valeriana wallichii on stress management: a clinical report. Nepal Med Coll J 2007; 9(1): 36-9.
[PMID: 17593676]
[261]
Benke D, Barberis A, Kopp S, et al. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 2009; 56(1): 174-81.
[http://dx.doi.org/10.1016/j.neuropharm.2008.06.013 ] [PMID: 18602406]
[262]
Becker A, Felgentreff F, Schröder H, Meier B, Brattström A. The anxiolytic effects of a Valerian extract is based on valerenic acid. BMC Complement Altern Med 2014; 14: 267.
[http://dx.doi.org/10.1186/1472-6882-14-267 ] [PMID: 25066015]
[263]
Andreatini R, Leite JR. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. Eur J Pharmacol 1994; 260(2-3): 233-5.
[http://dx.doi.org/10.1016/0014-2999(94)90342-5 ] [PMID: 7988648]
[264]
Andreatini R, Sartori VA, Seabra MLV, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 2002; 16(7): 650-4.
[http://dx.doi.org/10.1002/ptr.1027 ] [PMID: 12410546]
[265]
Andrade C, Aswath A, Chaturvedi SK, Srinivasa M, Raguram R. A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of Withania somnifera. Indian J Psychiatry 2000; 42(3): 295-301.
[PMID: 21407960]
[266]
Jahanbakhsh SP, Manteghi AA, Emami SA, et al. Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: a randomized double-blind placebo-controlled trial. Complement Ther Med 2016; 27: 25-9.
[http://dx.doi.org/10.1016/j.ctim.2016.03.018 ] [PMID: 27515872]
[267]
Fuladi S, Emami SA, Mohammadpour AH, Karimani A, Manteghi AA, Sahebkar A. Assessment of Withania somnifera root extract efficacy in patients with generalized anxiety disorder: a randomized double-blind placebo-controlled trial. Curr Clin Pharmacol 2020. Epub ahead of print
[http://dx.doi.org/10.2174/1574884715666200413120413 ] [PMID: 32282308]